Thomas Klis
Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $5,617 | 233 | 97.2% |
| Education | $162.94 | 2 | 2.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $1,474 | 72 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $980.73 | 25 | $0 (2024) |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $688.41 | 35 | $0 (2024) |
| Janssen Biotech, Inc. | $539.06 | 14 | $0 (2024) |
| Lilly USA, LLC | $393.95 | 18 | $0 (2024) |
| Dermavant Sciences, Inc. | $318.56 | 22 | $0 (2024) |
| GENZYME CORPORATION | $230.87 | 4 | $0 (2024) |
| PFIZER INC. | $196.83 | 10 | $0 (2024) |
| Incyte Corporation | $189.10 | 10 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $143.56 | 6 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,150 | 92 | Janssen Biotech, Inc. ($539.06) |
| 2023 | $1,137 | 58 | Sun Pharmaceutical Industries Inc. ($282.55) |
| 2022 | $437.90 | 23 | ABBVIE INC. ($167.45) |
| 2021 | $655.61 | 29 | AbbVie Inc. ($308.58) |
| 2020 | $288.92 | 12 | AbbVie Inc. ($207.43) |
| 2019 | $727.58 | 13 | Regeneron Healthcare Solutions, Inc. ($249.45) |
| 2018 | $382.43 | 8 | AbbVie, Inc. ($236.14) |
All Payment Transactions
235 individual payment records from CMS Open Payments — Page 1 of 10
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/20/2024 | Lilly USA, LLC | EBGLYSS (Drug) | Food and Beverage | In-kind items and services | $28.17 | General |
| Category: Immunology | ||||||
| 12/19/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $25.87 | General |
| Category: IMMUNOLOGY | ||||||
| 12/18/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | Winlevi (Drug) | Food and Beverage | In-kind items and services | $28.26 | General |
| Category: Dermatology | ||||||
| 12/18/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $5.99 | General |
| Category: DERMATOLOGY | ||||||
| 12/17/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $7.42 | General |
| Category: DERMATOLOGY | ||||||
| 12/12/2024 | Lilly USA, LLC | EBGLYSS (Drug) | Food and Beverage | In-kind items and services | $20.02 | General |
| Category: Immunology | ||||||
| 12/06/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $16.39 | General |
| Category: Dermatology | ||||||
| 12/05/2024 | Arcutis Biotherapeutics, Inc. | Zoryve (Drug) | Food and Beverage | In-kind items and services | $15.18 | General |
| Category: Dermatology | ||||||
| 12/04/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $3.72 | General |
| Category: DERMATOLOGY | ||||||
| 11/22/2024 | Verrica Pharmaceuticals Inc. | YCANTH (Drug) | Food and Beverage | In-kind items and services | $26.55 | General |
| Category: DERMATOLOGY | ||||||
| 11/20/2024 | Incyte Corporation | OPZELURA (Drug) | Food and Beverage | Cash or cash equivalent | $15.92 | General |
| Category: Dermatology | ||||||
| 11/20/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $5.10 | General |
| Category: DERMATOLOGY | ||||||
| 11/15/2024 | Lilly USA, LLC | EBGLYSS (Drug) | Food and Beverage | In-kind items and services | $25.45 | General |
| Category: Immunology | ||||||
| 11/14/2024 | Regeneron Healthcare Solutions, Inc. | LIBTAYO (Biological) | Food and Beverage | In-kind items and services | $28.86 | General |
| Category: ONCOLOGY | ||||||
| 11/14/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $4.60 | General |
| Category: DERMATOLOGY | ||||||
| 11/08/2024 | Lilly USA, LLC | EBGLYSS (Drug) | Food and Beverage | In-kind items and services | $25.78 | General |
| Category: Immunology | ||||||
| 11/08/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $9.00 | General |
| Category: IMMUNOLOGY | ||||||
| 11/08/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $2.94 | General |
| Category: IMMUNOLOGY | ||||||
| 11/07/2024 | LEO Pharma Inc. | ADBRY (Biological) | Food and Beverage | In-kind items and services | $22.64 | General |
| Category: DERMATOLOGY | ||||||
| 11/06/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $23.18 | General |
| Category: DERMATOLOGY | ||||||
| 10/25/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $21.27 | General |
| Category: Dermatology | ||||||
| 10/24/2024 | Janssen Biotech, Inc. | TREMFYA (Drug), SIMPONI, SIMPONI ARIA | Food and Beverage | In-kind items and services | $44.73 | General |
| Category: Immunology | ||||||
| 10/22/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $3.75 | General |
| Category: DERMATOLOGY | ||||||
| 10/19/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $1.83 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 10/18/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $32.64 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 10 | 958 | 1,750 | $327,120 | $85,392 |
| 2022 | 8 | 286 | 468 | $77,681 | $20,818 |
| 2021 | 10 | 214 | 340 | $52,983 | $20,164 |
All Medicare Procedures & Services
28 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 202 | 277 | $94,454 | $25,704 | 27.2% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 116 | 140 | $40,431 | $12,349 | 30.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 102 | 102 | $45,628 | $11,024 | 24.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 133 | 161 | $37,835 | $10,834 | 28.6% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 136 | 185 | $38,024 | $7,851 | 20.6% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 67 | 67 | $23,419 | $5,149 | 22.0% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 60 | 65 | $17,355 | $4,545 | 26.2% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 106 | 713 | $14,889 | $3,763 | 25.3% |
| 17004 | Destruction of precancer skin growth, 15 or more growths | Office | 2023 | 22 | 26 | $12,090 | $3,318 | 27.4% |
| 11200 | Removal of skin tag, 1-15 skin tags | Office | 2023 | 14 | 14 | $2,996 | $854.20 | 28.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 65 | 70 | $22,739 | $6,222 | 27.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 30 | 30 | $13,147 | $3,983 | 30.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 50 | 54 | $11,529 | $2,945 | 25.5% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2022 | 49 | 55 | $10,052 | $2,202 | 21.9% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2022 | 17 | 18 | $5,176 | $1,711 | 33.0% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2022 | 23 | 23 | $5,832 | $1,638 | 28.1% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 18 | 18 | $5,590 | $1,100 | 19.7% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2022 | 34 | 200 | $3,616 | $1,017 | 28.1% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 36 | 39 | $10,826 | $4,247 | 39.2% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 42 | 45 | $8,813 | $3,447 | 39.1% |
| 17004 | Destruction of 15 or more premalignant skin growths | Office | 2021 | 15 | 17 | $6,081 | $2,283 | 37.5% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 17 | 17 | $6,156 | $2,173 | 35.3% |
| 17110 | Destruction of up to 14 skin growths | Office | 2021 | 18 | 21 | $5,134 | $2,053 | 40.0% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 21 | 21 | $5,092 | $1,938 | 38.1% |
| 11102 | Tangential biopsy of single skin lesion | Office | 2021 | 18 | 19 | $4,248 | $1,654 | 38.9% |
About Thomas Klis
Thomas Klis is a Student in an Organized Health Care Education/Training Program healthcare provider based in Chicago, Illinois. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/28/2017. The National Provider Identifier (NPI) number assigned to this provider is 1952833154.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Thomas Klis has received a total of $5,780 in payments from pharmaceutical and medical device companies, with $2,150 received in 2024. These payments were reported across 235 transactions from 22 companies. The most common payment nature is "Food and Beverage" ($5,617).
As a Medicare-enrolled provider, Klis has provided services to 1,458 Medicare beneficiaries, totaling 2,558 services with total Medicare billing of $126,375. Data is available for 3 years (2021–2023), covering 28 distinct procedure/service records.
Practice Information
- Specialty Student in an Organized Health Care Education/Training Program
- Location Chicago, IL
- Active Since 03/28/2017
- Last Updated 03/28/2017
- Taxonomy Code 390200000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1952833154
Products in Payments
- DUPIXENT (Biological) $946.70
- SKYRIZI (Biological) $682.29
- TREMFYA (Drug) $539.06
- Winlevi (Drug) $370.78
- VTAMA (Drug) $318.56
- Humira (Biological) $318.20
- TALTZ (Drug) $270.66
- RINVOQ (Biological) $255.54
- ILUMYA (Biological) $235.94
- DUPIXENT (Drug) $223.61
- HUMIRA (Biological) $213.07
- EUCRISA (Drug) $196.83
- OPZELURA (Drug) $189.10
- Otezla (Drug) $171.87
- COSENTYX (Drug) $143.56
- LIBTAYO (Biological) $139.90
- EBGLYSS (Drug) $123.29
- Ilumya (Biological) $81.69
- YCANTH (Drug) $26.55
- ADBRY (Biological) $22.64
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Student in an Organized Health Care Education/Training Program Doctors in Chicago
Dr. Manish Jain, M.d, M.D
Student in an Organized Health Care Education/Training Program — Payments: $2.2M
Punita Gupta, M.d, M.D
Student in an Organized Health Care Education/Training Program — Payments: $187,045
Kristen Pallok, Md, MD
Student in an Organized Health Care Education/Training Program — Payments: $150,810
Dr. Aparna Kalyan, Md, MD
Student in an Organized Health Care Education/Training Program — Payments: $142,119
Dr. Edward Schaeffer, M.d., Phd, M.D., PHD
Student in an Organized Health Care Education/Training Program — Payments: $103,923
Dr. Gregory Lopez, Md, MD
Student in an Organized Health Care Education/Training Program — Payments: $101,966